Clover Biopharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Clover Biopharmaceuticals AUS Pty | Clover Biopharmaceuticals AUS Pty Ltd | Clover Biopharmaceuticals USA, LLC | CLOVER PHARMS | Zhejiang Clover Biopharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 18, 2018

Last known activity

Jun 18, 2025

Timeline

1960s

Mar 6, 1964
aminocaproic acid— NDA Organization
Jun 3, 1964
aminocaproic acid— NDA Secondary Org

2000s

Jan 1, 2007
Clover Biopharmaceuticals— Founded

Drugs by trial phase (19 distinct, 18 trials)

Phase 3 (9 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

scb-2020s

Phase 1 (9 own, 0 via acquisition)

Indications

Approved for

Hemorrhage

Studied for

Marketed drugs (1)

aminocaproic acid

Recent trials (19)

NCT06984094Lead sponsorPhase 1Jun 18, 2025
NCT06843317Lead sponsorPhase 1Mar 21, 2025
NCT06666179Lead sponsorPhase 1Mar 15, 2025
NCT06194318Lead sponsorPhase 1Dec 13, 2023
NCT06567457Lead sponsorPhase 3Oct 31, 2023
NCT05926440Lead sponsorPhase 3Aug 17, 2023
NCT05193279Lead sponsorPhase 2/Phase 3Jan 31, 2023
NCT05188677Lead sponsorPhase 3Jun 13, 2022
NCT05228314Lead sponsorPhase 1May 30, 2022
NCT05012787Lead sponsorPhase 3Sep 13, 2021
NCT04950751Lead sponsorPhase 2Aug 31, 2021
NCT04919096Lead sponsorPhase 1Aug 31, 2021
NCT04954131Lead sponsorPhase 2Aug 1, 2021
NCT04932824Lead sponsorPhase 1Jan 19, 2021
NCT04672395Study chairPhase 2/Phase 3Dec 31, 2020

Details

Founded: Chengdu, CN Jan 1, 2007
Last known activity: Jun 18, 2025

Designations held

Priority review